Skip to main content

Table 1 Demographic characteristics

From: Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging

Variable Overall Age ≥ 65 years
  NHANES Projected national estimate NHANES Projected national estimate
  N = 2915   N = 1466  
Mean (SE) age, years 63.9 (0.2) 61.4 (0.4) 73.4 (0.1) 73.1 (0.1)
Age ≥ 65 years, % (n) 50.3 (1466) 40.3 (N/A) 100 (1466) 100 (N/A)
Sex, % male (n) 52.0 (1517) 50.8 (N/A) 51.8 (760) 47.1 (N/A)
Mean (SE) diabetes duration, years 10.7 (0.2) 9.7 (0.2) 13.2 (0.3) 12.9 (0.3)
Mean (SE) eGFR (CKD-EPI), ml/min/1.73 m2 78.2 (0.5) 80.5 (0.5) 65.3 (0.6) 64.2 (0.8)
Mean (SE) eGFR (MDRD), ml/min/1.73 m2 78.5 (0.5) 79.1 (0.6) 66.7 (0.6) 64.8 (0.8)
Mean (SE) UAE, mg/g 109.7 (1.3) 109.1 (1.4) 103.4 (1.6) 99.1 (1.8)
Race/ethnicity     
Mexican American, % (n) 21.9 (638) 8.1 (N/A) 18.4 (269) 5.0 (N/Aa)
Other Hispanic, % (n) 7.9 (231) 5.9 (N/A) 6.0 (88) 3.4 (N/Aa)
Non-Hispanic white, % (n) 37.9 (1105) 62.6 (N/A) 47.0 (689) 72.6 (N/Aa)
Non-Hispanic black, % (n) 26.5 (773) 15.9 (N/A) 23.1 (338) 12.4 (N/Aa)
Other, including multiracial, % (n) 5.8 (168) 7.4 (N/A) 5.6 (82) 6.5 (N/Aa)
Comorbidities (self-reported)     
Hypertension, % (n)a 74.0 (2157) 71.9 (N/A) 80.3 (1177) 80.9 (N/Aa)
Retinopathy, % (n) 22.1 (645) 20.9 (N/A) 23.1 (339) 22.2 (N/Aa)
Coronary heart disease, % (n) 12.0 (351) 12.5 (N/A) 16.6 (243) 19.9 (N/Aa)
Myocardial infarction, % (n) 12.7 (371) 12.0 (N/A) 16.5 (241) 18.2 (N/Aa)
Congestive heart failure, % (n) 11.2 (326) 10.6 (N/A) 15.5 (227) 16.9 (N/Aa)
Angina, % (n) 9.0 (261) 9.5 (N/A) 11.4 (167) 13.9 (N/Aa)
Stroke, % (n) 10.1 (293) 9.1 (N/A) 13.6 (200) 14.4 (N/Aa)
  1. aN = 21,318,626 based on the total number of persons with diabetes who were age ≥ 18 years, NHIS 2012.